arXiv subjects

Abhijoy Sarkar

Publications and source records attributed to Abhijoy Sarkar.

3 recordsLinked to original sources

arXiv2026

Seeing Below the Limit of Detection: A Censored-Poisson Bayesian Latent-Growth Change-Point Detector (the Span Detector) for Serial ctDNA in HR+/HER2- Metastatic Breast Cancer

Circulating-tumour DNA (ctDNA) carries evidence of drug resistance months before imaging shows it, but the earliest evidence lives below the assay's limit of detection (LoD): a nascent subclone is detected only intermittently, producing a flickering sequence of faint detects and non-detects. Commercial liquid biopsies treat each draw as an independent snapshot and a non-detect as nothing. We argue a non-detect is a left-censored observation, and the pattern of non-detects and faint detects over time carries actionable evidence of growth before any single value is trustworthy. We introduce Span, a censored-Poisson Bayesian latent-growth change-point detector that models the binary detection process, accumulates a sequential generalised-likelihood-ratio statistic for an upward change-point in the per-variant detection rate, and raises a competing-risks alarm with calibrated false-alarm control. Span has no learned weights, so there is nothing to overfit. On a synthetic cohort of HR+/HER2- metastatic breast cancer on first-line CDK4/6-inhibitor plus endocrine therapy, at a matched 10% false-alarm rate, Span roughly doubles the fraction of impending progressions caught three months ahead (indolent regime: 25% vs 11% for the snapshot), with a falsifiable dose-response: large for indolent emergence, vanishing for fast emergence. A value-trajectory baseline performs identically to the snapshot, isolating the gain to the censored detection model. The survival backbone matches a Cox baseline on real breast-cancer data (GBSG-2, n=686; C-index 0.67 vs 0.68), and on a real longitudinal cohort with clean biomarkers (PBC2, n=312) the same pipeline correctly declines to win, a falsifiable boundary test confirming the mechanism is regime-specific. All ctDNA trajectories are synthetic.

q-bio.QM↗

arXiv2026

OncoTraj: a public benchmark for longitudinal resistance prediction in EGFR-mutant non-small-cell lung cancer on osimertinib

Resistance to first-line osimertinib in EGFR-mutant non-small-cell lung cancer (NSCLC) is the canonical example of predictable clonal evolution under therapeutic pressure, yet no public benchmark exists for training or evaluating computational models on the corresponding longitudinal patient trajectories. We introduce OncoTraj, a public benchmark of 813 EGFR-mutant NSCLC patients receiving first-line osimertinib, harmonized from three real-world clinical-genomic sources: MSK-CHORD (672 patients), AACR Project GENIE BPC NSCLC (34 patients), and the FLAURA molecular-resistance supplement (107 patients). OncoTraj defines three locked tasks: (A) binary classification of progression by a fixed 12-month landmark, (B) regression of time-to-first-progression in days, and (C) six-class classification of the dominant resistance mechanism. We release the harmonized dataset, patient-level train/validation/test splits with an audited no-leakage guarantee, an open-source evaluation harness, and six reference baselines spanning a majority-class predictor, logistic regression, random forest, XGBoost, an LSTM, and a multi-task transformer. With v1's single-timepoint snapshot features, no task clears chance on clean within-source evaluation: the uniformity of this ceiling across every model class localizes the limit to the input modality (single-snapshot tissue NGS rather than serial ctDNA), not the algorithm. The benchmark does recover a reproducible literature-consistent association: TP53 co-mutation raises the 12-month progression rate from 29% to 59% cohort-wide. OncoTraj establishes a reproducible, leakage-audited baseline and converts the modality limit into concrete design requirements for a serial-ctDNA-enriched v2.

cs.LG↗

arXiv2024

CompactifAI: Extreme Compression of Large Language Models using Quantum-Inspired Tensor Networks

Large Language Models (LLMs) such as ChatGPT and LlaMA are advancing rapidly in generative Artificial Intelligence (AI), but their immense size poses significant challenges, such as huge training and inference costs, substantial energy demands, and limitations for on-site deployment. Traditional compression methods such as pruning, distillation, and low-rank approximation focus on reducing the effective number of neurons in the network, while quantization focuses on reducing the numerical precision of individual weights to reduce the model size while keeping the number of neurons fixed. While these compression methods have been relatively successful in practice, there is no compelling reason to believe that truncating the number of neurons is an optimal strategy. In this context, this paper introduces CompactifAI, an innovative LLM compression approach using quantum-inspired Tensor Networks that focuses on the model's correlation space instead, allowing for a more controlled, refined and interpretable model compression. Our method is versatile and can be implemented with - or on top of - other compression techniques. As a benchmark, we demonstrate that a combination of CompactifAI with quantization allows to reduce a 93% the memory size of LlaMA 7B, reducing also 70% the number of parameters, accelerating 50% the training and 25% the inference times of the model, and just with a small accuracy drop of 2% - 3%, going much beyond of what is achievable today by other compression techniques. Our methods also allow to perform a refined layer sensitivity profiling, showing that deeper layers tend to be more suitable for tensor network compression, which is compatible with recent observations on the ineffectiveness of those layers for LLM performance. Our results imply that standard LLMs are, in fact, heavily overparametrized, and do not need to be large at all.

cs.CL↗